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Abstract Mycobacterium tuberculosis methionyl-tRNA synthe-
tase (MetRS) has been cloned and characterized. The protein
contains class I signature sequences but lacks the Zn2+ binding
motif and the C-terminal dimerization appendix that are found in
MetRSs from several organisms including E. coli MetRS.
Consistent with these features, the enzyme behaved as a
monomer in a gel filtration chromatography and did not contain
the bound Zn2+. Nonetheless, it was active to the tRNAMet of
E. coli as determined by in vivo genetic complementation and in
vitro reaction. Phylogenetic analysis separated the M. tubercu-
losis and E. coli MetRSs into prokaryote and eukaryote-archaea
group, respectively. This result is consistent with the taxonomic
locations of the organism but is an interesting contrast to the case
of its paralogous protein, isoleucyl-tRNA synthetase, and
suggests that the two enzymes evolved in separate idiosyncratic
pathways.
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1. Introduction
The aminoacyl-tRNA synthetases (aaRSs) catalyze the ¢rst
step in protein synthesis by covalently linking tRNA with its
cognate amino acid. Comparison of sequences and structural
information of these proteins from other organisms empha-
sizes the tremendous divergence of this family of enzymes
despite their common functions [1^3]. Mechanistic distinctions
among the tRNA synthetases [4] are further emphasized, for
example, through species-speci¢c RNA interactions which bar
cross-aminoacylation between eukaryotic and prokaryotic
tRNA and tRNA synthetase systems [5^7].
M. tuberculosis is an opportunistic agent that has re-
emerged resistant to multiple prominent anti-tuberculosis
treatments, promoting a search for new drugs [8]. The se-
quence and structural divergence of the tRNA synthetases
between organisms highlight these essential enzymes as ideal
targets to develop novel antibiotic agents. M. tuberculosis iso-
leucyl-tRNA synthetase (IleRS) was previously cloned, but
surprisingly the protein sequence was determined to be eu-
karyotic-like [9] and, moreover, resistant to the prokaryotic
IleRS-targeted antibiotic, pseudomonic acid [10,11]. IleRS is
closely related to several paralogous tRNA synthetases includ-
ing the methionine, valine, leucine, and cysteine enzymes [12]
which have been suggested to have evolved by gene duplica-
tion before the separation of the three taxonomic domains
[13]. Herein we report the cloning and characterization of
M. tuberculosis MetRS. Comparative sequence and structural
analyses of the protein revealed interesting features in its ac-
tivity and evolutionary pathway.
2. Materials and methods
Two combinations of degenerate primers were designed from
aligned MetRS sequences [14] to amplify a MetRS gene fragment
from M. kansasii chromosomal DNA by polymerase chain reaction
(PCR). The cloned PCR fragment was used to screen a Vgt11
M. tuberculosis library. The cloned M. tuberculosis MetRS gene was
engineered and cloned into pBluescript II SK (Stratagene) using
BamHI and EcoRI. The resulting recombinant pSLM101 expressed
the MetRS as an N-terminal L-galactosidase fusion protein. The pro-
tein was puri¢ed by (NH4)2SO4 fractionation and DEAE-Sephadex
chromatography [15]. The C-terminal truncated form of E. coli
MetRS was puri¢ed from E. coli expressing pJB104 as described pre-
viously [16]. The kinetic parameters for both proteins were measured
by in vitro aminoacylation of E. coli tRNAfMet (Sigma) [17]. In vivo
aminoacylation activity of the M. tuberculosis MetRS was conducted
using a E. coli strain MJR containing a defective MetRS that has a
high Km for methionine [18]. The recombinant plasmid, pSLM101,
was introduced into MJR to test whether the M. tuberculosis MetRS
rescues the methionine auxotrophy of the mutant strain. The sequence
of the M. tuberculosis MetRS was aligned with MetRS and IleRS
sequences from various organisms using the PILEUP program [19].
Gaps and less conserved sub-regions were deleted manually and the
remaining 298 residues were used for construction of a phylogenetic
tree. The maximum parsimony method was employed using the
PROTPARS program that was provided in the PHYLIP program
package [20]. A tree was also constructed by neighbor-joining using
PROTDIST (by invoking the Dayho¡ program option) and NEIGH-
BOR programs from the PHYLIP. Bootstrap analyses were per-
formed with 500 replicates using SEQBOOT and CONSENSE pro-
grams.
The enzyme bound Zn2 ion was determined using the sulfhydryl-
speci¢c reagent p-hydroxylmercuryphenylsulfonate (PMPS, Sigma),
which reacts with cysteines and forms a 250-nm complex, simultane-
ously releasing Zn2 into solution [21]. The free Zn2 is trapped
with 4-(2-pyridylazo)resorcinol (PAR, Sigma) that may be quantita-
tively detected at 500 nm [22,23]. The quaternary structure of
the protein was determined by high-performance liquid chromatogra-
phy (HPLC) analysis (Gynkotek) using size exclusion column
(TSK3000SW).
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3. Results and discussion
3.1. Sequence and structural characteristics
An open reading frame of 1557 base pairs encoding 519
amino acids was isolated from the genomic library of
M. tuberculosis. The N-terminal sequence which folds into
the Rossmann nucleotide binding pocket contains the con-
served class I signature sequence motifs as HVGH and
KMSKS and the C-terminal sequence contains proline and
tryptophan residues which are conserved across most of the
MetRS proteins (data not shown). However, the M. tubercu-
losis MetRS showed contrasting characteristics compared to
that of E. coli. The M. tuberculosis MetRS as well as other
parallel enzymes from Gram-positive bacteria and cyanobac-
teria lack an inserted peptide within the CP1 (connective poly-
peptide 1) region [24] that is found in those from eukaryote,
archaea, E. coli and H. in£uenzae (Fig. 1A). This CP1 region
contains four cysteines involved in binding to Zn2 that was
shown to be important to maintain the active conformation of
the catalytic site [21,23,25]. We predicted that the M. tuber-
culosis lacked a bound Zn2 and thus tested for its presence
using the sulfhydryl-speci¢c reagent, PMPS, which reacts with
cysteines to form a 250-nm complex, while releasing free Zn2
into solution. The released Zn2 was trapped with PAR that
may be quantitatively detected at 500 nm [22,23]. While
Zn2 [22,23] was released from the E. coli MetRS by the
treatment of PMPS, it was not observed for the M. tuber-
culosis MetRS (Fig. 1B), supporting the absence of a Zn2
binding pocket.
The C-terminal region, which contains the oligomerization
domain of the protein, is extremely divergent among all of the
MetRSs. The T. thermophilus and B. stearothermophilus en-
zymes are the only MetRSs that exhibit any signi¢cant ho-
mology in their dimerization regions. Although the M. tuber-
culosis MetRS is most closely related to these enzymes, it
lacks the entire dimerization domain (Fig. 1C). Speci¢cally,
the polypeptide contains only 519 amino acids, and thus is
signi¢cantly shorter than the other bacterial MetRS proteins
which range from 616 to 677 amino acids. The quaternary
structure of the protein was determined by chromatography
using a gel ¢ltration column. The native homodimer (676
amino acid protomer) [26] and genetically truncated monomer
(547 amino acids) [27] of the E. coli MetRS were used as a
reference. The dimeric and monomeric E. coli proteins were
eluted from the column at 20.31 and 23.50 min, respectively.
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Fig. 1. Sequence and structure of M. tuberculosis MetRS in the regions of Zn2 binding motif and C-terminal appendix. The M. tuberculosis
MetRS lacks (A) the Zn2 binding motif and (C) the C-terminal dimerization appendix. The sequence alignment of MetRSs from various or-
ganisms was made by the PILEUP program. The sequence numbers correspond to the amino acids of the M. tuberculosis MetRS. Cysteines in
the Zn2 binding motif were highlighted by boxes. B: The enzyme bound Zn2 was dissociated by chemical modi¢cation of cysteine using
PMPS which was monitored by the absorbance change at 250 nm (squares). The released Zn2 was measured by the absorbance change at
500 nm (circles). The Zn2 release was detected from the E. coli MetRS according to the amount of PMPS but not from the M. tuberculosis
MetRS. D: The quaternary structure of M. tuberculosis was determined by high pressure liquid chromatography using sizing column. The
M. tuberculosis MetRS contains 32 extra amino acids at its N-terminal end originating from L-galactosidase, resulting in a 551 amino acid
polypeptide. The native homodimer (676-mer protomer) and truncated monomer (547-mer) of the E. coli MetRS were used as size references.
The elution pro¢le of the M. tuberculosis MetRS suggests that it is a monomer.
Table 1
Kinetic parameters for aminoacylation of E. coli tRNAfMet
MetRS Km
(WM)
kcat
(s31)
kcat/Km Relative
kcat/Km
E. coli 1.0 6.85 6.85 1
M. tuberculosis 3.2 2.83 0.88 0.13
Each reaction contained 5 nM of MetRS and 0.1^80 WM E. coli
tRNAfMet and was carried out at 37‡C as described previously [17].
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M. tuberculosis MetRS was eluted at 23.38 min, suggesting a
monomeric protein (Fig. 1D).
3.2. In vivo and in vitro aminoacylation activity
The Zn2 binding to MetRS was previously shown to be
important for the enzyme activity [21,23,25] and the C-termi-
nal dimerization appendix is also involved in the interaction
with the acceptor stem of the bound tRNA [28]. We thus
investigated whether the M. tuberculosis MetRS lacking these
two peptide motifs is active in aminoacylating initiator tRNA
of E. coli. As shown in Table 1, the Km and kcat for the
recombinant M. tuberculosis MetRS were, respectively, about
3-fold higher and 2.5-fold lower compared to the E. coli
MetRS. In vitro aminoacylation experiments clearly showed
that M. tuberculosis MetRS recognizes E. coli tRNAfMet. This
result suggests that there should be alternative mechanisms to
yield a stable and active MetRS enzyme although the Zn2
binding motif within the CP1 domain is conserved among a
number of MetRS. Clearly, since a subset of the MetRSs (Fig.
1A) lacks the Zn2 binding motif, these enzymes have
adopted a di¡erent conformation, perhaps because of distinct
evolutionary pressures, to maintain an active catalytic do-
main.
Because E. coli uses an initiator and elongator tRNA for a
single methionine codon, the in vitro data did not conclude
whether the enzyme speci¢cally recognizes both types of
tRNAMet. We thus performed in vivo complementation tests
using a methionine auxotroph E. coli strain, MJR. The auxo-
trophy of this strain is due to the increased Km of its MetRS
for methionine. The introduction of pSLM101 expressing the
recombinant M. tuberculosis MetRS rescued the methionine-
dependent E. coli strain, indicating the M. tuberculosis MetRS
can speci¢cally charge both the initiator and elongator E. coli
tRNAMet (Fig. 2).
3.3. Phylogenetic relationship
While the M. tuberculosis MetRS contains the class I-de¢n-
ing signature sequences, it lacks a Zn2-binding motif and the
C-terminal dimerization appendix (Fig. 1). An evolutionary
path of MetRS was deduced through a phylogenetic tree
based on 13 MetRS and 17 IleRS protein sequences. Because
MetRS and IleRS have signi¢cant N-terminal sequence sim-
ilarities in the catalytic domain, an initial alignment was easily
generated by the PILEUP program. A phylogenetic tree was
constructed from the alignment using a parsimony method
described in Section 2.
The resulting phylogenetic tree of these proteins placed the
M. tuberculosis MetRS and IleRS into di¡erent lines of evo-
lution (Fig. 3, boxed). While the M. tuberculosis IleRS was
more eukaryotic-like as previously described [9,29], the
MetRS was closely related to the eubacterial type. The group-
ing of M. tuberculosis MetRS to the eubacterial MetRSs is
convincing since the branch between eubacteria and eukar-
yote-archaea group exhibits a 100% bootstrap value. We
also obtained a similar tree by neighbor-joining method
(data not shown). The tree placed the M. tuberculosis MetRS
in the clade consisting of S. cerevisiae mitochondrial, M. ge-
nitalium, M. pneumoniae, B. subtilis, B. stearothermophilus,
Synechocystis sp. and T.thermophilus MetRSs. Thus, M. tuber-
culosis MetRS and IleRS have evolved in di¡erent pathways,
although they may have originated from a common ancestor
by gene duplication before the diversi¢cation of eubacteria,
archaea and eukarya.
The phylogeny of the M. tuberculosis MetRS sequence is
more consistent with the other mycobacterial tRNA synthe-
tase sequences including seryl- and leucyl- (S. Martinis, un-
published data) and tyrosyl-tRNA synthetases [30], which are
also prokaryotic-like. IleRS (and GlyRS also) in this organism
show archaea-eukarya features and may be the result of hor-
izontal gene transfer from the archaea-eukarya domain into
the bacteria domain [29]. Unlike the more eukaryotic IleRS
which is resistant to the antibiotic, pseudomonic acid [9], M.
tuberculosis MetRS thus o¡ers more optimal molecular target
to screen for inhibitors which can distinguish the human
counterpart.
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Fig. 3. Phylogenetic relationship of M. tuberculosis MetRS and
IleRS. Numbers indicate the percent bootstrap value. The MetRS
and IleRS of M. tuberculosis are highlighted by boxes. The acces-
sion numbers for MetRS and IleRS proteins are shown below.
MetRS: S. cerevisiae mitochondrial (X14629); M. genitalium
(U39680); M. pneumoniae (P75091); B. subtilis (D26185); B. stearo-
thermophilus (X57925); Synechocystis sp. (D64002); T. thermophilus
(M64273); M. tuberculosis (this study); M. jannaschii (U67567);
S. cerevisiae (J01339); C. elegans (Z73427); H. in£uenzae (HI1276);
E. coli (J01649). IleRS: M. genitalium (B64238); M. pneumoniae
(U00089); Synechocystis sp. (D90907); S. cerevisiae mitochondrial
(L38957); C. elegans mitochondrial (Z81038); S. aureus (X74219);
C. jejuni (U15295); P. £uorescens (P18330); H. in£uenzae (P43824);
E. coli (D10483); S. aureus episomal (X75439); M. tuberculosis
([9]) ; S. cerevisiae (X07886); C. elegans (Z70310); H. sapiens ([5]) ;
M. jannaschii (Q58357); M. thermoautotrophicum (M59245).
Fig. 2. Complementation of M. tuberculosis MetRS in E. coli. Re-
combinant plasmids expressing the M. tuberculosis MetRS
(pSLM101) and the active monomeric E. coli MetRS (pJB104) were
introduced into the methionine auxotroph, E. coli MJR strain. The
in vivo activity of the plasmid-encoded proteins was assessed by the
ability to rescue the auxotrophy of the MJR strain.
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